drugset / Trial / NCT00746512

A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)

NCT00746512

Phase 1 Completed 45 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will compare the effects of prednisone vs placebo on synovial blood flow and overall DAS (disease activity score) in patients with rheumatoid arthritis.

Timeline

Start
2008-09
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 7.5 mg Oral
Subject Prednisone Other / unclassified 15 mg Oral

Indications